Profound, Cook Medical Sign Distribution Agreement

Hospitals gain a new integrated procurement route for the TULSA-PRO system via Cook Medical's Copernicus program.

Updated on Oct. 30, 2026 in Healthcare

Isometric editorial illustration of a modular medical scanner console in a clean, sterile clinical room. — Profound Medical and Cook Medical signed a U.S. distribution agreement to accelerate hospital adoption of the TULSA-PRO system through the Copernicus program. AI Illustration. Upload story photo >

Live Poll

Do you believe partnerships between medical companies help make advanced treatments more accessible for patients?

Profound Medical and Cook Medical have formed a U.S. distribution agreement that integrates the TULSA-PRO system into Cook Medical's Copernicus program. The partnership aims to accelerate hospital adoption of the TULSA procedure by combining Profound's technology with Cook Medical's established urology network.

Why it matters

This partnership targets hospitals investing in integrated MRI programs by lowering the barrier to entry for TULSA-PRO system adoption. By leveraging Cook Medical's sales footprint, Profound aims to expand its installed base and increase recurring revenue from follow-up treatment kits and service contracts.

The agreement shifts the distribution model for the TULSA-PRO system from a direct-only approach to a dual-channel strategy involving Cook Medical's Copernicus program. The total number of new hospital sites targeted for the system remains undisclosed.

The players

Profound Medical

A medical technology company based in Toronto that develops image-guided, incision-free procedures for prostate diseases.

Cook Medical

A Bloomington, Indiana-based medical device manufacturer known for its global footprint in minimally invasive urology products.

Siemens Healthineers

A multinational medical technology leader that collaborated with Cook Medical to develop the iMRI Suite.

The details

Under the agreement, Cook Medical will purchase TULSA-PRO systems at a predetermined transfer price for inclusion in their integrated procedural environments. While Cook manages system placement through the Copernicus program, Profound Medical maintains direct customer relationships for the recurring sale of treatment kits and ongoing service contracts. Profound will also continue to operate its own direct sales team for accounts that already utilize compatible MRI infrastructure.

October 30, 2026: Profound and Cook Medical announced the distribution agreement.

Market Landscape

This partnership utilizes the established iMRI Suite infrastructure to standardize how hospitals integrate advanced urological technology. It follows a growing industry trend of bundling specialized hardware into integrated procedural platforms to streamline hospital capital equipment procurement.

Hospital operators should evaluate if their current MRI suites can be retrofitted with the TULSA-PRO system under the new Copernicus program terms. Leadership teams should specifically monitor whether this integrated distribution model reduces the lead time for implementing specialized prostate treatment workflows.

The takeaway

The collaboration signals a move toward service-based integration where manufacturers prioritize recurring revenue streams over one-time system sales. Operators should track the expansion of the Copernicus program to determine if the bundled offering aligns with future capital equipment budgets.